Table 2.
Comparison of dichotomous patient characteristics between TF-TAVR and TC-TAVR cohorts.
| Characteristics | Number of studies (references) | TC-TAVR | TF-TAVR | P-value | ||
|---|---|---|---|---|---|---|
| n | % | n | % | |||
| Male gender | All (11, 20–27) | 822 | 59.8 | 2,115 | 57.1 | 0.077 |
| Comorbidities | ||||||
| •HTA | 7 (11, 21, 22, 24–27) | 326 | 85.1 | 1,676 | 82.1 | 0.150 |
| •CAD | 4 (11, 20, 21, 26) | 724 | 64.6 | 2,307 | 60.5 | 0.020 |
| •Previous cardiac surgery | 6 (11, 20, 22–25) | 311 | 26.3 | 649 | 22.4 | 0.008 |
| •Diabetes | All (11, 20–27) | 453 | 33.0 | 1,153 | 31.1 | 0.206 |
| •PAD | 8 (11, 20–22, 24–27) | 680 | 52.6 | 1,199 | 32.8 | <0.001 |
| •COPD | 8 (11, 20–22, 24–27) | 331 | 25.7 | 916 | 25.1 | 0.712 |
| •TIA/stroke | All (11, 20–27) | 193 | 14.0 | 493 | 13.3 | 0.491 |
STS, score: Society of Surgeons score; HTA, hypertension; CAD, coronary artery disease; PAD, peripheral artery disease; COPD, chronic obstructive pulmonary disease; TIA, transient ischemic attack; TC, transcarotid; TF, transfemoral; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel.